Literature DB >> 20142310

Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions.

Konstantin E Balashov1, Gian Pal, Michael L Rosenberg.   

Abstract

Optic neuritis (ON) patients can be divided into two groups based on the presence or absence of asymptomatic demyelinating lesions (ADLs) on brain MRI. The presence of ADLs is associated with an increased risk of progression to clinically definite multiple sclerosis (CDMS). The clinical data and brain MRI of 110 patients with acute unilateral ON were analyzed. Patients with ADLs had a significantly higher incidence of ON in spring months as compared with patients with no ADLs (p = 0.0024). Increased incidence of ON in spring months was seen in patients with ADLs whether or not they were diagnosed with CDMS on follow-up.

Entities:  

Mesh：

Year:  2010        PMID： 20142310      PMCID： PMC2861653          DOI： 10.1177/1352458509355070

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  9 in total

1.  Effects of seasons on magnetic resonance imaging--measured disease activity in patients with multiple sclerosis.

Authors:  M Rovaris; G Comi; M P Sormani; J S Wolinsky; D Ladkani; M Filippi
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

2.  Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

Authors:  D P Auer; E M Schumann; T Kümpfel; C Gössl; C Trenkwalder
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

3.  Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis.

Authors:  Y Jin; J de Pedro-Cuesta; M Söderström; L Stawiarz; H Link
Journal:  J Neurol Sci       Date:  2000-12-01       Impact factor: 3.181

4.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

Authors:  J I O'Riordan; A J Thompson; D P Kingsley; D G MacManus; B E Kendall; P Rudge; W I McDonald; D H Miller
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

5.  The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.

Authors: 
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

7.  Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

Authors:  J Killestein; M H Rep; F Barkhof; M T Roos; H J Adèr; R A van Lier; C H Polman
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

8.  Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.

Authors:  Helen Tremlett; Ingrid A F van der Mei; Fotini Pittas; Leigh Blizzard; Glenys Paley; Desiree Mesaros; Richard Woodbaker; Manuel Nunez; Terence Dwyer; Bruce V Taylor; Anne-Louise Ponsonby
Journal:  Neuroepidemiology       Date:  2008-10-30       Impact factor: 3.282

9.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Authors:  Peter A Brex; Olga Ciccarelli; Jonathon I O'Riordan; Michael Sailer; Alan J Thompson; David H Miller
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245
  9 in total
  2 in total

Review 1.  Optic neuritis.

Authors:  D Pau; N Al Zubidi; S Yalamanchili; G T Plant; A G Lee
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

2.  Optic neuritis as first clinical manifestations the multiple sclerosis.

Authors:  Emina Alimanovic Halilovic; Ilda Alimanovic; Enra Suljic; Nabil Al Hassan
Journal:  Mater Sociomed       Date:  2014-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.